National Noncompete Ban Unlikely to Survive Under Trump, Experts Say

BFV shareholders Benjamin Fink and Neal Weinrich provide commentary for Medscape Medical News on the likelihood of survival of the Federal Trade Commission’s national ban on noncompete agreements under the Trump administration. The noncompete ban, which was found invalid in several court rulings which are being appealed, would have a significant impact on physicians, hospitals, and other healthcare providers, particularly in states like Georgia where noncompete agreements have previously been permitted.

Read more at Medscape.com. Please note: To view the entire article (and all other content on Medscape from WebMD), a one-time registration is needed, which is free of charge.